Regen BioPharma, Inc. (RGBPP) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 La Mesa, CA, 美国. 现任CEO为 David Raymond Koos.
RGBPP 拥有 IPO日期为 2016-04-20, 1 名全职员工, 在 Other OTC, 市值为 $193.98K.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
